Obesity and downregulated hypothalamic leptin receptors in male metallothionein-3-null mice

Neurobiology of Disease

Volumn 44, Issue 1, 2011, Pages 125-132

  Byun, Hyae Ran ^a   Kim, Dong Kyu ^a   Koh, Jae Young ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Hyperleptinemia; Leptin receptor; Metabolic rate; Metallothionein 3; Obesity; Zinc

Indexed keywords

LEPTIN; LEPTIN RECEPTOR; METALLOTHIONEIN III; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBON METABOLISM; CONTROLLED STUDY; CORRELATIONAL STUDY; DOWN REGULATION; ENZYME ACTIVATION; FOOD INTAKE; HYPOTHALAMUS; MALE; METABOLIC DISORDER; METABOLIC RATE; NONHUMAN; NULL ALLELE; OBESITY; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION; WEIGHT GAIN; WILD TYPE; ZINC METABOLISM;

ANIMALS; BLOTTING, WESTERN; BODY WEIGHT; CELLS, CULTURED; DOWN-REGULATION; EATING; ENERGY METABOLISM; HYPOTHALAMUS; LEPTIN; MALE; METALS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NERVE TISSUE PROTEINS; OBESITY; OXYGEN CONSUMPTION; RECEPTORS, LEPTIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 79961128226     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2011.06.012     Document Type: Article

References (51)

1. Aschner M., et al. Metallothioneins in brain-the role in physiology and pathology. Toxicol. Appl. Pharmacol. 1997, 142:229-242.
2. Batty G.D., et al. Obesity and overweight in relation to organ-specific cancer mortality in London (UK): findings from the original Whitehall study. Int. J. Obes. (Lond.) 2005, 29:1267-1274.
3. Beach L.R., Palmiter R.D. Amplification of the metallothionein-I gene in cadmium-resistant mouse cells. Proc. Natl. Acad. Sci. U. S. A. 1981, 78:2110-2114.
4. Beattie J.H., et al. Obesity and hyperleptinemia in metallothionein (-I and -II) null mice. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:358-363.
5. Benomar Y., et al. In vivo leptin infusion impairs insulin and leptin signalling in liver and hypothalamus. Mol. Cell. Endocrinol. 2005, 242:59-66.
6. Beyersmann D., Haase H. Functions of zinc in signaling, proliferation and differentiation of mammalian cells. Biometals 2001, 14:331-341.
7. Bjorbaek C., Kahn B.B. Leptin signaling in the central nervous system and the periphery. Recent Prog. Horm. Res. 2004, 59:305-331.
8. Bjorbaek C., et al. Divergent signaling capacities of the long and short isoforms of the leptin receptor. J. Biol. Chem. 1997, 272:32686-32695.
9. Bjorbaek C., et al. Divergent roles of SHP-2 in ERK activation by leptin receptors. J. Biol. Chem. 2001, 276:4747-4755.
10. Brown C.D., et al. Body mass index and the prevalence of hypertension and dyslipidemia. Obes. Res. 2000, 8:605-619.
11. Calle E.E., et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N. Engl. J. Med. 2003, 348:1625-1638.
12. Carrasco J., et al. Enhanced seizures and hippocampal neurodegeneration following kainic acid-induced seizures in metallothionein-I+II-deficient mice. Eur. J. Neurosci. 2000, 12:2311-2322.
13. Chua S.C., et al. Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor. Science 1996, 271:994-996.
14. de Luca C., et al. Complete rescue of obesity, diabetes, and infertility in db/db mice by neuron-specific LEPR-B transgenes. J. Clin. Invest. 2005, 115:3484-3493.
15. Durnam D.M., Palmiter R.D. Analysis of the detoxification of heavy metal ions by mouse metallothionein. Experientia Suppl. 1987, 52:457-463.
16. Erickson J.C., et al. Disruption of the metallothionein-III gene in mice: analysis of brain zinc, behavior, and neuron vulnerability to metals, aging, and seizures. J. Neurosci. 1997, 17:1271-1281.
17. Garcia O.P., et al. Impact of micronutrient deficiencies on obesity. Nutr. Rev. 2009, 67:559-572.
18. Heiat A., et al. An evidence-based assessment of federal guidelines for overweight and obesity as they apply to elderly persons. Arch. Intern. Med. 2001, 161:1194-1203.
19. Hochberg I., Hochberg Z. Hypothalamic obesity. Endocr. Dev. 2010, 17:185-196.
20. Hozumi I., et al. Metallothionein-3 is expressed in the brain and various peripheral organs of the rat. Neurosci. Lett. 2008, 438:54-58.
21. Humphreys M.H. Cardiovascular and renal actions of melanocyte-stimulating hormone peptides. Curr. Opin. Nephrol. Hypertens. 2007, 16:32-38.
22. Jequier E. Leptin signaling, adiposity, and energy balance. Ann. N. Y. Acad. Sci. 2002, 967:379-388.
23. Kagi J.H., Kojima Y. Chemistry and biochemistry of metallothionein. Experientia Suppl. 1987, 52:25-61.
24. Kagi J.H., et al. Metallothionein: an exceptional metal thiolate protein. CIBA Found. Symp. 1979, 223-237.
25. Kenchaiah S., et al. Obesity and the risk of heart failure. N. Engl. J. Med. 2002, 347:305-313.
26. Lee G.H., et al. Abnormal splicing of the leptin receptor in diabetic mice. Nature 1996, 379:632-635.
27. Lee J.Y., et al. Zinc released from metallothionein-iii may contribute to hippocampal CA1 and thalamic neuronal death following acute brain injury. Exp. Neurol. 2003, 184:337-347.
28. Li G., et al. Unabated anorexic and enhanced thermogenic responses to melanotan II in diet-induced obese rats despite reduced melanocortin 3 and 4 receptor expression. J. Endocrinol. 2004, 182:123-132.
29. Lichtlen P., Schaffner W. The "metal transcription factor" MTF-1: biological facts and medical implications. Swiss Med. Wkly. 2001, 131:647-652.
30. Masters B.A., et al. Metallothionein III is expressed in neurons that sequester zinc in synaptic vesicles. J. Neurosci. 1994, 14:5844-5857.
31. Misigoj-Durakovic M., Durakovic Z. The early prevention of metabolic syndrome by physical exercise. Coll. Antropol. 2009, 33:759-764.
32. Nejat E.J., et al. Predictors of chronic disease at midlife and beyond-the health risks of obesity. Maturitas 2010, 65:106-111.
33. Palmiter R.D. Molecular biology of metallothionein gene expression. Experientia Suppl. 1987, 52:63-80.
34. Palmiter R.D., et al. MT-III, a brain-specific member of the metallothionein gene family. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:6333-6337.
35. Park J.A., Koh J.Y. Induction of an immediate early gene egr-1 by zinc through extracellular signal-regulated kinase activation in cortical culture: its role in zinc-induced neuronal death. J. Neurochem. 1999, 73:450-456.
36. Penkowa M., et al. CNS wound healing is severely depressed in metallothionein I- and II-deficient mice. J. Neurosci. 1999, 19:2535-2545.
37. Penkowa M., et al. Impaired inflammatory response to glial cell death in genetically metallothionein-I- and -II-deficient mice. Exp. Neurol. 1999, 156:149-164.
38. Perusse L., et al. The human obesity gene map: the 2004 update. Obes. Res. 2005, 13:381-490.
39. Pritchard L.E., et al. Pro-opiomelanocortin processing in the hypothalamus: impact on melanocortin signalling and obesity. J. Endocrinol. 2002, 172:411-421.
40. Quaife C.J., et al. Induction of a new metallothionein isoform (MT-IV) occurs during differentiation of stratified squamous epithelia. Biochemistry 1994, 33:7250-7259.
41. Rahmouni K., et al. Hypothalamic ERK mediates the anorectic and thermogenic sympathetic effects of leptin. Diabetes 2009, 58:536-542.
42. Satoh M., et al. Protective role of metallothionein in renal toxicity of cisplatinum. Cancer Chemother. Pharmacol. 1997, 40:358-362.
43. Satoh M., et al. Enhanced renal toxicity by inorganic mercury in metallothionein-null mice. J. Pharmacol. Exp. Ther. 1997, 283:1529-1533.
44. Schwartz M.W., et al. Model for the regulation of energy balance and adiposity by the central nervous system. Am. J. Clin. Nutr. 1999, 69:584-596.
45. Seidell J.C. Obesity, insulin resistance and diabetes-a worldwide epidemic. Br. J. Nutr. 2000, 83(Suppl. 1):S5-S8.
46. Sims E.A., et al. Endocrine and metabolic effects of experimental obesity in man. Recent Prog. Horm. Res. 1973, 29:457-496.
47. Stevens J., et al. Sensitivity and specificity of anthropometrics for the prediction of diabetes in a biracial cohort. Obes. Res. 2001, 9:696-705.
48. Sweeney G. Leptin signalling. Cell. Signal. 2002, 14:655-663.
49. Trendelenburg G., et al. Serial analysis of gene expression identifies metallothionein-II as major neuroprotective gene in mouse focal cerebral ischemia. J. Neurosci. 2002, 22:5879-5888.
50. Yoneshiro T., et al. Brown adipose tissue, whole-body energy expenditure, and thermogenesis in healthy adult men. Obesity 2011, 19:13-16.
51. Zhang Y., et al. Positional cloning of the mouse obese gene and its human homologue. Nature 1994, 372:425-432.